Much of the published work on the use of MR imaging in experimental models seems to fall into two categories. The first are articles that focus on the use of MR imaging to visualize the known histologic effects of a pathologic process and its treatment. This research is extremely important in translation to the bedside, because clinical trials are often dependent on imaging findings. In addition, the use of MR imaging to evaluate an animal model serially saves time and money, because large numbers of animals need not be sacrificed at multiple time points to obtain significant results. The second are articles that focus on presenting new imaging techniques and/or pulse sequences, with the application to an experimental model used to confirm underlying hypotheses of the imaging physics, not necessarily the pathologic process. These new imaging techniques may then be tested with a variety of diseases and subsequently find their way into the clinic as an improved method of diagnosis. Less frequently seen, however, is a third category of research in which MR imaging is used as a tool to support hypotheses regarding pathophysiologic mechanisms.
In this issue of AJNR, the article by Berens et al appears to fall into both the first and third categories. They have used MR imaging both to visualize the known histologic effects in an animal model of posttraumatic cavity formation and as a research tool to determine whether blood–spinal cord barrier (BSCB) disruption may play an important role in this pathologic process. Their experimental model is an intraspinal injection of quisqualic acid (QUIS), which simulates injury-induced elevations of excitatory amino acids (EAAs). There were differing effects of the QUIS, depending on injection depth in white matter, with deeper injections resulting in spinal cord cavities that have histologic features similar to those seen following traumatic spinal cord injury. The known histologic findings of this model, such as cysts and hemorrhage, are clearly seen on their in vivo MR images, a finding that supports the utility of MR imaging in following the pathologic progression of these lesions. More interesting, however, is the use of dynamic contrast-enhanced MR imaging to determine whether there was disruption of the BSCB, which could potentially contribute to cyst formation.
Disruption of the BSCB following traumatic spinal cord injury may be an important cause of propagating injury following spinal cord trauma and is therefore a potential target for therapy (1). Loss of BSCB integrity appears to be biphasic. There is primary mechanical disruption of the spinal vasculature at the time of traumatic injury resulting in hemorrhage and ischemia. There is then a cascade of secondary events, including toxicity from blood products, as well as EAAs, which are the focus of the experimental model in this article. The secondary injury, however, is due to not just the sequelae of mechanical disruption; there is a second phase of BSCB permeability that begins 3–4 days following initial injury (2) and may last up to 28 days. This second phase of BSCB disruption may result in more injury to the spinal cord, allowing entry of inflammatory cells and small toxic molecules into the extracellular space. Subsequently, there is increased tissue damage, including areas of intact spinal cord adjacent to the central hemorrhagic core. Because protection of <10% of axons in spinal cord white matter may result in significant functional recovery (3), this penumbra of tissue surrounding the central hemorrhagic core may be a promising target for therapy.
In the current article, the authors imaged the spinal cords at 17–24 days following injury and they found no evidence of BSCB disruption. This finding may not be surprising, in view of research indicating that the BSCB is no longer permeable to large molecules at 21–28 days postinjury. It will be interesting to see whether there is leakage of the BSCB soon after QUIS injection and whether the degree and duration of BSCB leakage predicts or quantifies future cavity formation. Perhaps intrinsic differences in neuronal response to QUIS injections, and the subsequent effect on vascular integrity, will help explain the lack of cavity formation in the shallower QUIS injections.
Although the vascular events following spinal cord injury are complex, it is clear that the integrity and permeability of the BSCB is an important factor and a potential therapeutic target. The issue of BSCB integrity and its relation to secondary injury is being addressed in the neuroscience literature. One line of research has involved matrix metalloproteinases (MMPs), which are excessively expressed by inflammatory cells following spinal cord injury. MMPs are thought to increase BSCB permeability, thus resulting in an influx of inflammatory cells and EAAs that are toxic to the spinal cord. Mice that do not express these proteinases, as well as mice administered an MMP inhibitor, show improved recovery to spinal cord injury (4, 5). These articles utilized histologic techniques for evaluating the BSCB, such as staining for immunoglobulin G leakage or measuring leakage of intravenously injected macromolecules through the BSCB. All these methods, however, are performed postmortem and thus at only one time point. Although the feasibility of serially evaluating the disruption, and subsequent restoration, of the BSCB in vivo following injury has been demonstrated for years (6, 7), the use of MR imaging as a neuroscience tool has not been fully exploited. Perhaps we need to educate our basic science colleagues about the utility of MR imaging as a primary research tool, above and beyond the translational aspect.
References
- Copyright © American Society of Neuroradiology